Research ArticleOriginal Article
Open Access

Poloxamer 188 alleviates cerebral ischemia-reperfusion injury in mice by reducing mitochondrial and lysosomal membrane damage

Hui Xu, Zhanhu Zhang, Xiaodong Tao, Ruirui Shi, Jian Xu, Xiaohua Zhang and Jinhua Gu
Neurosciences Journal July 2025, 30 (3) 216-225; DOI: https://doi.org/10.17712/nsj.2025.3.20240025

References

  1. 1.↵
    1. Zhou X,
    2. Deng X,
    3. Liu M,
    4. He M,
    5. Long W,
    6. Xu Z, et al.
    Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy. J Control Release 2023; 357: 1-19.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Lu Y,
    2. Zhou M,
    3. Li Y,
    4. Li Y,
    5. Hua Y,
    6. Fan Y.
    Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1/STAT6 pathways. Biochem Pharmacol 2021; 186: 114464.
    OpenUrlPubMed
  3. 3.↵
    1. Zhang M,
    2. Lu H,
    3. Xie X,
    4. Shen H,
    5. Li X,
    6. Zhang Y, et al.
    TMEM175 mediates Lysosomal function and participates in neuronal injury induced by cerebral ischemia-reperfusion. Mol Brain 2020; 13: 113.
    OpenUrlPubMed
  4. 4.↵
    1. Yang Y,
    2. Liu Q,
    3. Deng S,
    4. Shao Q,
    5. Peng L,
    6. Ling Y, et al.
    Human umbilical cord derived mesenchymal stem cells overexpressing HO-1 attenuate neural injury and enhance functional recovery by inhibiting inflammation in stroke mice. CNS Neurosci Ther 2024; 30: e14412.
    OpenUrlPubMed
  5. 5.↵
    1. Tsivgoulis G,
    2. Katsanos AH,
    3. Sandset EC,
    4. Turc G,
    5. Nguyen TN,
    6. Bivard A, et al.
    Thrombolysis for acute ischaemic stroke: current status and future perspectives. Lancet Neurol 2023;22:418-29.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Ding W,
    2. Lin H,
    3. Hong X,
    4. Ji D,
    5. Wu F.
    Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson’s disease. Toxicology 2020; 436: 152437.
    OpenUrlPubMed
  7. 7.↵
    1. Moloughney JG,
    2. Weisleder N.
    Poloxamer 188 (p188) as a membrane resealing reagent in biomedical applications. Recent Pat Biotechnol 2012; 6: 200-211.
    OpenUrlPubMed
  8. 8.↵
    1. Wu R,
    2. Koduri R,
    3. Cho M,
    4. Alatrash N,
    5. Nomellini V.
    Effects of poloxamer 188 on traumatic brain injury. Brain Behav Immun Health 2024; 38: 100762.
    OpenUrlPubMed
  9. 9.↵
    1. Colbassani HJ,
    2. Barrow DL,
    3. Sweeney KM,
    4. Bakay RA,
    5. Check IJ,
    6. Hunter RL.
    Modification of acute focal ischemia in rabbits by poloxamer 188. Stroke 1989; 20: 1241-1246.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Gu JH,
    2. Ge JB,
    3. Li M,
    4. Xu HD,
    5. Wu F,
    6. Qin ZH
    . Poloxamer 188 protects neurons against ischemia/reperfusion injury through preserving integrity of cell membranes and blood brain barrier. PLoS One 2013; 8: e61641.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Zhang Y,
    2. Shen L,
    3. Xie J,
    4. Li L,
    5. Xi W,
    6. Li B, et al.
    Pushen capsule treatment promotes functional recovery after ischemic stroke. Phytomedicine 2023; 111: 154664.
    OpenUrlPubMed
  12. 12.↵
    1. Guo K,
    2. Shang Y,
    3. Wang Z,
    4. Li Y,
    5. Chen J,
    6. Zhu B, et al.
    BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia-reperfusion. Int Immunopharmacol 2023; 119: 110201.
    OpenUrlPubMed
  13. 13.↵
    1. Chen WN,
    2. Shaikh MF,
    3. Bhuvanendran S,
    4. Date A,
    5. Ansari MT,
    6. Radhakrishnan AK, et al.
    Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic Review. Curr Neuropharmacol 2022; 20: 799-808.
    OpenUrlPubMed
  14. 14.↵
    1. Lotze FP,
    2. Riess ML.
    Poloxamer 188 Exerts Direct Protective Effects on Mouse Brain Microvascular Endothelial Cells in an In Vitro Traumatic Brain Injury Model. Biomedicines 2021; 9.
  15. 15.↵
    1. Wang T,
    2. Chen X,
    3. Wang Z,
    4. Zhang M,
    5. Meng H,
    6. Gao Y, et al.
    Poloxamer-188 can attenuate blood-brain barrier damage to exert neuroprotective effect in mice intracerebral hemorrhage model. J Mol Neurosci 2015; 55: 240-250.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Liu A,
    2. Hu J,
    3. Yeh TS,
    4. Wang C,
    5. Tang J,
    6. Huang X, et al.
    Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives. Curr Neuropharmacol 2023; 21: 2283-2309.
    OpenUrlPubMed
  17. 17.↵
    1. Zhu S,
    2. Liu S,
    3. Wang L,
    4. Ding W,
    5. Sha J,
    6. Qian H, et al.
    Brusatol Protects HepG2 Cells against Oxygen-Glucose Deprivation-Induced Injury via Inhibiting Mitochondrial Reactive Oxygen Species-Induced Oxidative Stress. Pharmacology 2020; 105: 416-423.
    OpenUrlPubMed
  18. 18.↵
    1. Ge J,
    2. Lin H,
    3. Yang J,
    4. Li Q,
    5. Zhou J,
    6. Qin Z, et al.
    TP53-induced glycolysis and apoptosis regulator (TIGAR) ameliorates lysosomal damage in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-mediated mouse model of Parkinson’s disease. Toxicol Lett 2021; 339: 60-69.
    OpenUrlPubMed
  19. 19.↵
    1. Zargari M,
    2. Meyer LJ,
    3. Riess ML,
    4. Li Z,
    5. Barajas MB.
    P188 Therapy in In Vitro Models of Traumatic Brain Injury. Int J Mol Sci 2023; 24.
  20. 20.↵
    1. Pille JA,
    2. Riess ML.
    Potential Effects of Poloxamer 188 on Rat Isolated Brain Mitochondria after Oxidative Stress In Vivo and In Vitro. Brain Sci 2021; 11.
  21. 21.↵
    1. Marks JD,
    2. Pan CY,
    3. Bushell T,
    4. Cromie W,
    5. Lee RC. Amphiphilic
    , tri-block copolymers provide potent membrane-targeted neuroprotection. FASEB J 2001; 15: 1107-1109.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Hill CS,
    2. Coleman MP,
    3. Menon DK.
    Traumatic Axonal Injury: Mechanisms and Translational Opportunities. Trends Neurosci 2016; 39: 311-324.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Dong H,
    2. Qin Y,
    3. Huang Y,
    4. Ji D,
    5. Wu F. Poloxamer
    188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson’s disease. Neurochem Int 2019; 126: 178-186.
    OpenUrlPubMed
  24. 24.↵
    1. Luo C,
    2. Li Q,
    3. Gao Y,
    4. Shen X,
    5. Ma L,
    6. Wu Q, et al.
    Poloxamer 188 Attenuates Cerebral Hypoxia/Ischemia Injury in Parallel with Preventing Mitochondrial Membrane Permeabilization and Autophagic Activation. J Mol Neurosci 2015; 56: 988-998.
    OpenUrlPubMed
  25. 25.↵
    1. Chen S,
    2. Zhang J,
    3. Li M,
    4. Zhou J,
    5. Zhang Y.
    Danhong injection combined with tPA protects the BBB through Notch-VEGF signaling pathway on long-term outcomes of thrombolytic therapy. Biomed Pharmacother 2022; 153: 113288.
    OpenUrlPubMed
  26. 26.↵
    1. Gu JH,
    2. Ge JB,
    3. Li M,
    4. Wu F,
    5. Zhang W,
    6. Qin ZH.
    Inhibition of NF-kappaB activation is associated with anti-inflammatory and anti-apoptotic effects of Ginkgolide B in a mouse model of cerebral ischemia/reperfusion injury. Eur J Pharm Sci 2012; 47: 652-660.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section